Amundi’s Korro Bio KRRO Stock Holding History

Amundi’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,493	Closed	-$420K	–	1691
2022 Q1	$420K	Sell	5,493 -168	-3%	-$32.1K	﹤0.01%	1311
2021 Q4	$1.47M	Buy	5,661 +133	+2%	+$40.4K	﹤0.01%	1233
2021 Q3	$1.95M	Sell	5,528 -9,994	-64%	-$3.93M	﹤0.01%	1197
2021 Q2	$7.73M	Buy	+15,522	New	+$7.58M	0.01%	906

Other funds holding KRRO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Amundi's KRRO Position: Q2 2022 in Review

Amundi sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 5,493 shares — an estimated $420K sold.

Amundi first reported a position in KRRO in Q2 2021 and held it in 4 quarters. The position peaked at $7.73M in Q2 2021. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

Amundi reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
Amundi sold 5,493 Korro Bio shares in Q2 2022, an estimated $420K.
Amundi first reported a position in Korro Bio in Q2 2021 and held it in 4 quarters.
Amundi's Korro Bio position peaked at $7.73M in Q2 2021.
58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.